Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis

E. V. Esaulenko; O. E. Nikitina; N. V. Dunaeva; A. N. Uskov; T. L. Mogilevets

doi:10.22625/2072-6732-2011-3-3-42-45

Журнал инфектологии (Sep 2014)

Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis

E. V. Esaulenko,
O. E. Nikitina,
N. V. Dunaeva,
A. N. Uskov,
T. L. Mogilevets

Affiliations

E. V. Esaulenko: Saint-Petersburg State Pediatric Medical Academy, Saint-Petersburg
O. E. Nikitina: Research Institute of Influenza, Saint-Petersburg
N. V. Dunaeva: Research Institute of Influenza, Saint-Petersburg
A. N. Uskov: Research Institute of Children Infection Diseases FMBA of Russia, Saint-Petersburg
T. L. Mogilevets: Yaroslav-the-Wise Novgorod State University, Velikiy Novgorod

DOI: https://doi.org/10.22625/2072-6732-2011-3-3-42-45
Journal volume & issue: Vol. 3, no. 3
pp. 42 – 45

Abstract

Read online

Patients with chronic virus hepatitis (32 patients, 13 with chronic hepatitis B and 19 with chronic hepatitis C) ages from 20 to 72 with elevated levels of bilirubin and active alanine aminotransferase, aspartate aminotransferase, gamma- glutamyl transpeptidase, received ursodeoxycholic acid (Urdoxa) over the course of 12 weeks. During therapy alanine aminotransferase, aspartate aminotransferase, bilirubin and gamma-glutamyl transpeptidase levels decreased. Urdoxa demonstrated good tolerance, efficacy and no visible side effects. Thus, Urdoxa could be used in treatment of chronic viral hepatitis with cytolytic and cholestatic syndromes.

Published in Журнал инфектологии

ISSN: 2072-6732 (Print)
Publisher: Journal Infectology
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: http://journal.niidi.ru/

About the journal

Abstract

Keywords